Source: Annual Congress 2003 - Mesothelioma and malignant effusions
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
G. Ak, M. Metintas, S. Metintas, S. Erginel, I. Ucgun, F. Alatas (Eskisehir, Turkey). Appropriateness between UICC and IMIG staging systems in management of malignant pleural mesothelioma. Eur Respir J 2003; 22: Suppl. 45, 501

Member's Comments

No comment yet.

Related content which might interest you: Diagnosis and staging of malignant pleural mesothelioma Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases Year: 2020 Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines Year: 2009 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Eur Respir J, 55 (6) 1900953; 10.1183/13993003.00953-2019 Year: 2020 ERS/ESTS/EACTS/ESTRO guidelines for the management of malignant pleural mesothelioma Source: Guideline 2020 Year: 2020 Diagnosis and staging of mesothelioma Source: Eur Respir Mon; 2009: 44: 392–406 Year: 2009 Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma Source: ISSN=ISSN 1810-6838, ISBN=, page=173 Year: 2005 Haematologic parameters and their prognostic impact in malignant pleural mesothelioma Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 Malignant pleural mesothelioma in our material: evaluation by EORTC prognostic scoring system Source: Eur Respir J 2001; 18: Suppl. 33, 396s Year: 2001 Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 EBUS-TBNA, EUS-FNA or EUS-B-FNA for mediastinal staging of lung cancer: A purpose of diagnostic algorithm Source: International Congress 2014 – Diagnosis of pleural effusions and mediastinal adenopathies Year: 2014 The analysis of clinicopathological characteristics and prognosis of malignant pleural mesothelioma Source: Annual Congress 2013 –Diagnosis and management of pleural and mediastinal diseases Year: 2013 The relation between clinical tumor stage and metastasis according to sixth TNM staging and new revised TNM staging in non-small lung cancer patients Source: Annual Congress 2010 - Staging of lung cancer Year: 2010 Prognostic impact of histology and treatment modalities in malignant mesothelioma Source: Annual Congress 2013 –Clinical problems in mediastinal and pleural malignacies Year: 2013 Endosonographic mediastinal assessment in Lung Ca staging and beyond Source: ERS Course: Interventional bronchoscopy Year: 2019 Lent score validation on patients with malignant pleural effusion Source: International Congress 2016 – Malignant pleural disease: diagnosis and management Year: 2016 Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Management of malignant pleural mesothelioma Source: ERS Skills Course 2015 Year: 2015 Management of malignant pleural mesothelioma Source: School Course 2014 - Medical Thoracoscopy Year: 2014 Management of malignant pleural mesothelioma Source: Hands-on Course 2012 - Medical Thoracoscopy Year: 2012 Management of malignant pleural mesothelioma Source: ERS Course 2016 - Skills course on medical thoracoscopy Year: 2016